| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0315 | 6f-trp | Novel probe for detecting tryptophan metabolites in ex vivo tissue samples via 19F nuclear magnetic resonance |
|
| DCC0316 | 6-hydroxymyosmine | Nornicotine metabolite |
|
| DCC0317 | 6jc48-1 | Novel inhibitor of Lipid II with less cytotoxicity and improved pharmacokinetic profile |
|
| DCC0318 | 6k-f17 TFA salt | Novel cationic antimicrobial peptide (CAP) |
|
| DCC0319 | 6-mbc-camp | Selective agonist of protein kinase A, strongly preferring the A site of cAK II |
|
| DCC0320 | 6n-fam | Novel high-affinity NR5A probe for fluorescence polarization competition assays, tightly binding the NR5A receptors and detecting direct binding of synthetic and phospholipid ligands |
|
| DCC0321 | 6-nonylpyridine-2,4-diol | Novel highly potent agonist of GPR84 |
|
| DCC0322 | 6-o-acetylglycitin | Metabolite of soy isoflavone, preventing bone loss and reversing the unfavorable changes of lipid metabolism |
|
| DCC0323 | 6-oh-bta-0 | The precursor for preparing 11C-PiB, a β-amyloid PET imaging tracer for Alzheimer's disease diagnosis |
|
| DCC0324 | 6pgd-in-s3 | Novel inhibitor of 6-phosphogluconate dehydrogenase (6PGD) |
|
| DCC0325 | 6'-ß-fluoro-homoaristeromycin | Novel potent inhibitor of chikungunya virus (CHIKV) replication |
|
| DCC0326 | 6-thioguanosine Monophosphate Sodium Salt | Thiopurine metabolite, blocking activation of GTPase Rac1 in T lymphocytes |
|
| DCC0327 | 6α-methylprednisone | Glucocorticoid with anti-inflammatory and immunosuppressive activities |
|
| DCC0328 | 7-(r)-hydroxystearic Acid | Novel potent cell growth inhibitor, suppressing the cytokine-Induced β-cell apoptosis |
|
| DCC0329 | 7,8,3'-trihydroxyflavone | Agonist of tyrosine receptor kinase B (TrkB) |
|
| DCC0330 | 780-5fu | Novel NIR fluorescent heptamethine cyanine dye IR-780 and 5FU conjugate, exhibiting enhanced CSCs-targeting therapeutic effects |
|
| DCC0331 | 7alpha-acetoxy-6beta-hydroxyroyleanone | Natural antiplasmodial agent |
|
| DCC0332 | 7cn-thiq | Ligand binding to the orthosteric site of D2 receptor |
|
| DCC0333 | 7-diethylamino-4-hydroxy-chromen-2-one | Useful pharmaceutical building block |
|
| DCC0334 | 7-elca | Novel Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist, Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating Glucagon-like Peptide-1 Secretion From Enteroendocrine Cells |
|
| DCC0335 | 7-hcaa | Fluorescent amino acid for protein labeling |
|
| DCC0336 | 7-hydroxyneolamellarin A | Natural hypoxia-inducible factor-1α (HIF-1α) inhibitor, targeting the protein activity which could stabilize HIF-1α |
|
| DCC0337 | 7-meota | Potent inhibitor of AChE in treatment of cognitive manifestation of AD |
|
| DCC0338 | 7-nina | Non-selective NOS inhibitor |
|
| DCC0339 | 7-nitrocalindol Hydrochloride | Potent and selective calcium sensing receptor agonist |
|
| DCC0340 | 7-oxo-staurosporine (chair Isomer) | Potent dual PKCθ/δ inhibitor, efficiently inhibiting tumor growth in pancreatic cancer (PC) by inducing cellular apoptosis and suppressing the NF-κB/p-P65 pathway |
|
| DCC0341 | 7-troc-paclitaxel | Precursor of paclitaxel, a anti-tumor agent |
|
| DCC0342 | 808-nm2 | Novel tumor-targeting NIR fluorophore-conjugated hypoxic tumor inhibitor, preferentially accumulating in hypoxic tumor cells, sensitively outlining the tumor contour, and effectively inhibiting tumor growth synergistically by chemotherapy and radiotherapy |
|
| DCC0343 | 8-aaf-dg | Carcinogenic adduct, covalently binding DNA bases and promoting mutagenesis near the adduct site |
|
| DCC0344 | 8-aha-2-cl-camp | Novel activator of cAMP-dependent protein kinase (PKA) with high selectivity for site B-I of PKA |
|
